Formosa Laboratories, Inc.(TW:4746)
NT$45.40+0.25 (+0.55%)
TW:4746
Formosa Laboratories, Inc. financials statements
NT$45.40
At close:+0.25 (+0.55%)
Formosa Laboratories, Inc. (4746) Income Statement
Formosa Laboratories, Inc. Income Statement
Last quarter (Q2 2026), Formosa Laboratories, Inc.'s total revenue was NT$1.11B, a decrease of 10.60% from the same quarter last year. In Q2, Formosa Laboratories, Inc.'s net income was NT$-14.48M. See Formosa Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 4.85B | NT$ 4.73B | NT$ 4.36B | NT$ 3.77B | NT$ 3.14B | |
| NT$ 2.03B | NT$ 2.05B | NT$ 1.92B | NT$ 1.39B | NT$ 971.44M | |
| NT$ 1.23B | NT$ 1.30B | NT$ 1.25B | NT$ 1.20B | NT$ 1.15B | |
| Depreciation and Amortization | NT$ 549.08M | NT$ 506.93M | NT$ 488.33M | NT$ 470.92M | NT$ 475.00M |
| NT$ 1.35B | NT$ 746.86M | NT$ 1.16B | NT$ 823.41M | NT$ 1.59B | |
| NT$ 803.18M | NT$ 750.04M | NT$ 674.98M | NT$ 380.85M | NT$ 1.10B | |
| NT$ -301.43M | NT$ -551.89M | NT$ -532.58M | NT$ -47.67M | NT$ 1.26B | |
| NT$ 501.75M | NT$ 198.15M | NT$ 142.39M | NT$ 333.18M | NT$ 1.09B | |
| NT$ 441.11M | NT$ 157.27M | NT$ 126.24M | NT$ 216.81M | NT$ 1.25B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 3.67 | NT$ 1.31 | NT$ 1.05 | NT$ 1.80 | NT$ 10.92 |
| Diluted EPS | NT$ 3.67 | NT$ 1.30 | NT$ 1.05 | NT$ 1.79 | NT$ 10.32 |
| Weighted Average Shares Outstanding | 107.91M | 120.26M | 120.23M | 120.26M | 114.36M |
| Weighted Average Shares Outstanding (Diluted) | 107.91M | 120.26M | 120.49M | 120.88M | 121.50M |
Currency in TWD

